These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18438784)

  • 1. HFE mutations in nonalcoholic fatty liver disease.
    Valenti L; Dongiovanni P; Fracanzani AL; Fargion S
    Hepatology; 2008 May; 47(5):1794-5; author reply 1795-6. PubMed ID: 18438784
    [No Abstract]   [Full Text] [Related]  

  • 2. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.
    Nelson JE; Bhattacharya R; Lindor KD; Chalasani N; Raaka S; Heathcote EJ; Miskovsky E; Shaffer E; Rulyak SJ; Kowdley KV
    Hepatology; 2007 Sep; 46(3):723-9. PubMed ID: 17680648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime?
    Bhattacharya R; Kowdley KV
    Gastroenterology; 2003 Aug; 125(2):615-6; discussion 617. PubMed ID: 12891567
    [No Abstract]   [Full Text] [Related]  

  • 4. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India.
    Dhillon BK; Das R; Garewal G; Chawla Y; Dhiman RK; Das A; Duseja A; Chandak GR
    World J Gastroenterol; 2007 Jun; 13(21):2956-9. PubMed ID: 17589946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of iron in nonalcoholic fatty liver disease: the story continues.
    Kowdley KV
    Gastroenterology; 2010 Mar; 138(3):817-9. PubMed ID: 20116466
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Loria P; Lonardo A; Carulli N
    Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.
    Zamin I; Mattos AA; Mattos AZ; Migon E; Bica C; Alexandre CO
    Arq Gastroenterol; 2006; 43(3):224-8. PubMed ID: 17160239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HFE mutations analysis of Turkish patients with nonalcoholic steatohepatitis.
    Simsek H; Balaban YH; Sümer H; Yilmaz E; Tatar G
    Dig Dis Sci; 2006 Oct; 51(10):1723-4. PubMed ID: 16964543
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.
    Raszeja-Wyszomirska J; Kurzawski G; Lawniczak M; Miezynska-Kurtycz J; Lubinski J
    World J Gastroenterol; 2010 May; 16(20):2531-6. PubMed ID: 20503453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.
    Valenti L; Dongiovanni P; Fracanzani AL; Santorelli G; Fatta E; Bertelli C; Taioli E; Fiorelli G; Fargion S
    Dig Liver Dis; 2003 Mar; 35(3):172-8. PubMed ID: 12779071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations.
    Neri S; Pulvirenti D; Signorelli S; Ignaccolo L; Tsami A; Mauceri B; Misseri M; Interlandi D; Cutuli N; Castellino P
    Intern Med J; 2008 Apr; 38(4):254-8. PubMed ID: 17916170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
    World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
    Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Hernaez R; Yeung E; Clark JM; Kowdley KV; Brancati FL; Kao WH
    J Hepatol; 2011 Nov; 55(5):1079-85. PubMed ID: 21354231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for non-HFE linked hemochromatosis in Asian Indians.
    Panigrahi I; Ahmad F; Kapoor R; Sharma PK; Makharia G; Saxena R
    Indian J Med Sci; 2006 Dec; 60(12):491-5. PubMed ID: 17130663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.
    Duseja A; Das R; Nanda M; Das A; Garewal G; Chawla Y
    World J Gastroenterol; 2005 Jan; 11(3):393-5. PubMed ID: 15637751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
    Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
    Nelson JE; Brunt EM; Kowdley KV;
    Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.